Ionis Pharmaceuticals enters exclusive olezarsen license agreement with Sobi
Ionis Pharmaceuticals (IONS) announced that it has entered into a license agreement under which Sobi received exclusive rights in countries ...
Mira Pharmaceuticals signs binding LOI to acquire SKNY Pharmaceuticals
MIRA Pharmaceuticals (MIRA) has signed a binding letter of intent to acquire SKNY Pharmaceuticals. The transaction includes a $5M capital ...
Morningstar14d
CASI Pharmaceuticals Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
gc.cuny16d
Center on Philanthropy and Civil Society
The Center on Philanthropy and Civil Society is committed to strengthening civil society through education, research, and leadership training. An integral part of The Graduate Center (GC), the Center ...
Mena FN16d
Endo Announces Divestiture Of International Pharmaceuticals Business
March 11, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI ) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business ...